(Q38045918)

27 August 2017

title

Influenza vaccines: T-cell responses deserve more attention (English)

1 reference

27 August 2017

1 reference

1 reference

3

Geert Leroux-Roels

0 references

Michael Schotsaert

series ordinal

1

object named as

Michael Schotsaert

1 reference

27 August 2017

2

Xavier Saelens

1 reference

27 August 2017

publication date

1 August 2012

1 reference

Expert Review of Vaccines

27 August 2017

published in

1 reference

27 August 2017

volume

11

1 reference

27 August 2017

issue

8

1 reference

27 August 2017

page(s)

949-962

1 reference

27 August 2017

1 reference

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine

21 January 2018

1 reference

The need for quadrivalent vaccine against seasonal influenza

21 January 2018

1 reference

Influenza and the challenge for immunology

21 January 2018

1 reference

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

21 January 2018

1 reference

Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children

21 January 2018

1 reference

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

21 January 2018

1 reference

Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses

21 January 2018

1 reference

Cytotoxic T-cell immunity to influenza.

21 January 2018

1 reference

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

21 January 2018

1 reference

Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance

21 January 2018

1 reference

Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes

21 January 2018

1 reference

Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes

21 January 2018

1 reference

Cross-reactive CD8 + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses

21 January 2018

1 reference

Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells

21 January 2018

1 reference

Human memory CTL response specific for influenza A virus is broad and multispecific

21 January 2018

1 reference

Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes

21 January 2018

1 reference

Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus

21 January 2018

1 reference

Time lines of infection and disease in human influenza: a review of volunteer challenge studies

21 January 2018

1 reference

Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus

21 January 2018

1 reference

Defective ribosomal products are the major source of antigenic peptides endogenously generated from influenza A virus neuraminidase

21 January 2018

1 reference

Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells

21 January 2018

1 reference

Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.

21 January 2018

1 reference

Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus

21 January 2018

1 reference

Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory

21 January 2018

1 reference

Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets

21 January 2018

1 reference

Prior infection of pigs with swine influenza viruses is a barrier to infection with avian influenza viruses.

21 January 2018

1 reference

Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.

21 January 2018

1 reference

Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets

21 January 2018

1 reference

REACTIONS OF MONKEYS TO EXPERIMENTALLY INDUCED INFLUENZA VIRUS A INFECTION : AN ANALYSIS OF THE RELATIVE ROLES OF HUMORAL AND CELLULAR IMMUNITY UNDER CONDITIONS OF OPTIMAL OR DEFICIENT NUTRITION.

21 January 2018

1 reference

Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates

21 January 2018

1 reference

Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population

21 January 2018

1 reference

Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009

21 January 2018

1 reference

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

21 January 2018

1 reference

Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung.

21 January 2018

1 reference

Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection

21 January 2018

1 reference

Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice

21 January 2018

1 reference

Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin

21 January 2018

1 reference

Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10.

21 January 2018

1 reference

The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections

21 January 2018

1 reference

The route of priming influences the ability of respiratory virus-specific memory CD8+ T cells to be activated by residual antigen

21 January 2018

1 reference

Effector and memory CTL differentiation

21 January 2018

1 reference

Inflammatory chemokine receptors regulate CD8(+) T cell contraction and memory generation following infection

21 January 2018

1 reference

Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses.

21 January 2018

1 reference

Poverty, wealth, and access to pandemic influenza vaccines.

21 January 2018

1 reference

Declining T-cell immunity to influenza, 1977-82

21 January 2018

1 reference

On natural and artificial vaccinations

21 January 2018

1 reference

Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants

21 January 2018

1 reference

Current status and progress of prepandemic and pandemic influenza vaccine development.

21 January 2018

1 reference

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

21 January 2018

1 reference

H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses.

21 January 2018

1 reference

Effect on cellular and humoral immune responses of the AS03 adjuvant system in an A/H1N1/2009 influenza virus vaccine administered to adults during two randomized controlled trials.

21 January 2018

1 reference

Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines.

21 January 2018

1 reference

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

21 January 2018

1 reference

Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.

21 January 2018

1 reference

Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses.

21 January 2018

1 reference

Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine

21 January 2018

1 reference

Humoral and cell-mediated immunity to vero cell-derived influenza vaccine

21 January 2018

1 reference

A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

21 January 2018

1 reference

Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions

21 January 2018

1 reference

Developing vaccines against pandemic influenza

21 January 2018

1 reference

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

21 January 2018

1 reference

The cross-priming pathway: a portrait of an intricate immune system

21 January 2018

1 reference

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

21 January 2018

1 reference

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children

21 January 2018

1 reference

Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children

21 January 2018

1 reference

Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery

21 January 2018

1 reference

Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.

21 January 2018

1 reference

Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model

21 January 2018

1 reference

Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.

21 January 2018

1 reference

21 January 2018

1 reference

Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.

21 January 2018

1 reference

Early priming minimizes the age-related immune compromise of CD8⁺ T cell diversity and function

21 January 2018

1 reference

Recombinant neuraminidase vaccine protects against lethal influenza.

21 January 2018

1 reference

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

21 January 2018

1 reference

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans

21 January 2018

1 reference

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

21 January 2018

1 reference

Yearly influenza vaccinations: a double-edged sword?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.12.71

1 reference

27 August 2017

1 reference